{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:59:31Z","timestamp":1788566371796,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01\u2010HC\u201025195"],"award-info":[{"award-number":["N01\u2010HC\u201025195"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K24-DK110550"],"award-info":[{"award-number":["K24-DK110550"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["2015-703787"],"award-info":[{"award-number":["2015-703787"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00125-018-4599-x","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T11:21:57Z","timestamp":1524136917000},"page":"1315-1324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose"],"prefix":"10.1007","volume":"61","author":[{"given":"Jordi","family":"Merino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ti","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Porneala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Walford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"von Grotthuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Flannick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Gerszten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C.","family":"Florez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Meigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"4599_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387:1513\u20131530","journal-title":"Lancet"},{"key":"4599_CR2","first-page":"1545","volume":"388","author":"GBD","year":"2015","unstructured":"GBD (2015) Disease and Injury Incidence and Prevalence Collaborators (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1545\u20131602","journal-title":"Lancet"},{"key":"4599_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403","journal-title":"N Engl J Med"},{"key":"4599_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","unstructured":"Diabetes Prevention Program Research Group (2015) Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3:866\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4599_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/archinte.167.10.1068","volume":"167","author":"PWF Wilson","year":"2007","unstructured":"Wilson PWF, Meigs JB, Sullivan L et al (2007) Prediction of incident diabetes mellitus in middle-aged adults. Arch Intern Med 167:1068","journal-title":"Arch Intern Med"},{"key":"4599_CR6","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1056\/NEJMoa050080","volume":"353","author":"A Tirosh","year":"2005","unstructured":"Tirosh A, Shai I, Tekes-Manova D et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454\u20131462","journal-title":"N Engl J Med"},{"key":"4599_CR7","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1001\/jama.285.16.2109","volume":"285","author":"F de Vegt","year":"2001","unstructured":"de Vegt F, Dekker JM, Jager A et al (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 285:2109\u20132113","journal-title":"JAMA"},{"key":"4599_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2337\/dc10-0644","volume":"34","author":"SH Choi","year":"2011","unstructured":"Choi SH, Kim TH, Lim S et al (2011) Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 34:944\u2013949","journal-title":"Diabetes Care"},{"key":"4599_CR9","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2337\/dc14-2814","volume":"38","author":"RM Anjana","year":"2015","unstructured":"Anjana RM, Shanthi Rani CS, Deepa M et al (2015) Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 38:1441\u20131448","journal-title":"Diabetes Care"},{"key":"4599_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311\u2013326","journal-title":"Cell Metab"},{"key":"4599_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448\u2013453","journal-title":"Nat Med"},{"key":"4599_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee EP, Cheng S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402\u20131411","journal-title":"J Clin Invest"},{"key":"4599_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","volume":"15","author":"CB Newgard","year":"2012","unstructured":"Newgard CB (2012) Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15:606\u2013614","journal-title":"Cell Metab"},{"key":"4599_CR14","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1172\/JCI64801","volume":"123","author":"TJ Wang","year":"2013","unstructured":"Wang TJ, Ngo D, Psychogios N et al (2013) 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest 123:4309\u20134317","journal-title":"J Clin Invest"},{"key":"4599_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639\u2013648","journal-title":"Diabetes"},{"key":"4599_CR16","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.2337\/dc14-0560","volume":"37","author":"GA Walford","year":"2014","unstructured":"Walford GA, Porneala BC, Dauriz M et al (2014) Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care 37:2508\u20132514","journal-title":"Diabetes Care"},{"key":"4599_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1373\/clinchem.2014.228965","volume":"61","author":"D Drogan","year":"2015","unstructured":"Drogan D, Dunn WB, Lin W et al (2015) Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin Chem 61:487\u2013497","journal-title":"Clin Chem"},{"key":"4599_CR18","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2337\/db15-1063","volume":"65","author":"GA Walford","year":"2016","unstructured":"Walford GA, Ma Y, Clish C et al (2016) Metabolite profiles of diabetes incidence and intervention response in the Diabetes Prevention Program. Diabetes 65:1424\u20131433","journal-title":"Diabetes"},{"key":"4599_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a112813","volume":"110","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, Feinleib M, McNamara PM et al (1979) An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110:281\u2013290","journal-title":"Am J Epidemiol"},{"key":"4599_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/msb.2008.50","volume":"4","author":"O Shaham","year":"2008","unstructured":"Shaham O, Wei R, Wang TJ et al (2008) Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 4:214","journal-title":"Mol Syst Biol"},{"key":"4599_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"4599_CR22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"4599_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R (1996) Regression shrinkage and selection via the Lasso on JSTOR. J R Stat Soc 58:267\u2013288","journal-title":"J R Stat Soc"},{"key":"4599_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"key":"4599_CR25","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia J, Sinelnikov IV, Han B, Wishart DS (2015) MetaboAnalyst 3.0\u2013making metabolomics more meaningful. Nucleic Acids Res 43:W251\u2013W257","journal-title":"Nucleic Acids Res"},{"key":"4599_CR26","doi-asserted-by":"publisher","first-page":"11122","DOI":"10.1038\/ncomms11122","volume":"7","author":"J Kettunen","year":"2016","unstructured":"Kettunen J, Demirkan A, W\u00fcrtz P et al (2016) Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun 7:11122","journal-title":"Nat Commun"},{"key":"4599_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature18642","volume":"536","author":"C Fuchsberger","year":"2016","unstructured":"Fuchsberger C, Flannick J, Teslovich TM et al (2016) The genetic architecture of type 2 diabetes. Nature 536:41\u201347","journal-title":"Nature"},{"key":"4599_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37:658\u2013665","journal-title":"Genet Epidemiol"},{"key":"4599_CR29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512\u2013525","journal-title":"Int J Epidemiol"},{"key":"4599_CR30","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W et al (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379:2279\u20132290","journal-title":"Lancet"},{"key":"4599_CR31","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2337\/dc16-0232","volume":"39","author":"L Sun","year":"2016","unstructured":"Sun L, Liang L, Gao X et al (2016) Early prediction of developing type 2 diabetes by plasma acylcarnitines: a population-based study. Diabetes Care 39:1563\u20131570","journal-title":"Diabetes Care"},{"key":"4599_CR32","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1007\/s00125-017-4325-0","volume":"60","author":"G Peddinti","year":"2017","unstructured":"Peddinti G, Cobb J, Yengo L et al (2017) Early metabolic markers identify potential targets for the prevention of type 2 diabetes. Diabetologia 60:1740\u20131750","journal-title":"Diabetologia"},{"key":"4599_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF01659328","volume":"1","author":"G Kikuchi","year":"1973","unstructured":"Kikuchi G (1973) The glycine cleavage system: composition, reaction mechanism, and physiological significance. Mol Cell Biochem 1:169\u2013187","journal-title":"Mol Cell Biochem"},{"key":"4599_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferre","year":"2016","unstructured":"Guasch-Ferre M, Hruby A, Toledo E et al (2016) Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 39:833\u2013846","journal-title":"Diabetes Care"},{"key":"4599_CR35","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2337\/db12-0876","volume":"62","author":"W Xie","year":"2013","unstructured":"Xie W, Wood AR, Lyssenko V et al (2013) Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes 62:2141\u20132150","journal-title":"Diabetes"},{"key":"4599_CR36","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00125-017-4222-6","volume":"60","author":"Y Mahendran","year":"2017","unstructured":"Mahendran Y, Jonsson A, Have CT et al (2017) Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia 60:873\u2013878","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4599-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:49:07Z","timestamp":1720226947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4599-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4599"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4599-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JCF has received consulting honoraria from Boehringer-Ingelheim, Merck and Intarcia Therapeutics. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}